Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: SJG-136 in Treating Patients With Relapsed or Refractory Acute Leukemia, Myelodysplastic Syndromes, Blastic Phase Chronic Myelogenous Leukemia, or Chronic Lymphocytic Leukemia [Phase 1]
Phase 1 trial of SJG-136 in relapsed or refractory hematologic cancers (acute myeloid leukemia subtypes, myelodysplastic syndromes, blast-ph…
-
CLINICAL_TRIALS trial_result · 2013-09-27Clinical Trial Update: A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid Leukaemia [Phase 2]
A Phase 2 trial evaluated elacytarabine (CP-4055) plus idarubicin as a second-course remission-induction therapy for acute myeloid leukemia.…
-
CLINICAL_TRIALS trial_result · 2013-09-27Clinical Trial Update: Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML) [Phase 3]
Clinical trial comparing elacytarabine to investigator's choice in late-stage acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2013-09-27Clinical Trial Update: Lenalidomide Maintenance Therapy in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) [Phase 2]
A Phase 2 trial evaluating lenalidomide maintenance therapy in patients with myelodysplastic syndromes or acute myeloid leukemia was termina…
-
CLINICAL_TRIALS trial_result · 2013-09-23Clinical Trial Update: The Pharmacokinetics and Cardiac Properties of Elacytarabine (CP-4055) [Phase 1]
Phase 1 study of elacytarabine (CP-4055) evaluating pharmacokinetics and cardiac properties in relapsed/refractory acute myeloid leukemia. T…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia [Phase 3]
This entry reports a Phase 3 clinical trial evaluating combination chemotherapy in older patients with acute myeloid leukemia; the current s…
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia [Phase 1]
A Phase 1 trial evaluating the combination of entinostat and sorafenib in patients with advanced or metastatic solid tumors or relapsed/refr…
-
CLINICAL_TRIALS trial_result · 2013-09-18Clinical Trial Update: A Phase I/II Study of CP-4055 in Patients With Refractory/Relapsed Hematologic Malignancies [Phase 1, Phase 2]
Clinical trial update reporting completion of a Phase 1/2 study of CP-4055 in patients with refractory/relapsed hematologic malignancies, in…
-
CLINICAL_TRIALS trial_result · 2013-09-18Clinical Trial Update: PET-CT in AML for Detection of Extramedullary AML Manifestations
Clinical trial update indicating completion of a study evaluating PET-CT for detecting extramedullary manifestations in patients with newly …
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Everolimus, Cytarabine, and Daunorubicin in Treating Patients With Relapsed Acute Myeloid Leukemia [Phase 1]
Phase 1 clinical trial evaluating the safety and preliminary activity of combining everolimus with cytarabine and daunorubicin in relapsed a…
-
CLINICAL_TRIALS trial_result · 2013-08-26Clinical Trial Update: Study of Obatoclax in Previously Untreated Acute Myeloid Leukemia (AML) [Phase 2]
Phase 2 clinical trial of obatoclax in previously untreated acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-26Clinical Trial Update: Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes [Phase 2, Phase 3]
This clinical trial update notes a completed Phase 2/Phase 3 study evaluating combination chemotherapy with or without gemtuzumab ozogamicin…
-
CLINICAL_TRIALS trial_result · 2013-08-14Clinical Trial Update: Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic Malignancies [NA]
This clinical trial update indicates that a pilot study of umbilical cord blood transplantation in adults with advanced hematopoietic malign…
-
CLINICAL_TRIALS trial_result · 2013-08-09Clinical Trial Update: Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (H-R MDS) [Phase 2]
Phase 2 clinical trial update reporting results for the combination of decitabine and gemtuzumab ozogamicin in acute myeloid leukemia and hi…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 1]
This trial update reports the completion of a Phase 1 study evaluating amifostine in combination with chemotherapy for newly diagnosed acute…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic Malignancies
The trial evaluating reduced-intensity umbilical cord blood transplantation in adults with advanced hematopoietic malignancies has been term…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Unrelated Stem Cell Transplantation for Adults With Hematopoietic Disorders
This clinical trial update notes the completion of an unrelated donor stem cell transplantation study in adults with hematopoietic disorders…
-
CLINICAL_TRIALS trial_result · 2013-08-01Clinical Trial Update: Revlimid in Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome [Phase 2]
This is a Phase 2 clinical trial update reporting results for lenalidomide (Revlimid) in patients with acute myeloid leukemia and myelodyspl…
-
CLINICAL_TRIALS trial_result · 2013-07-31Clinical Trial Update: LAM07: Study to Analyze the Efficacy of a Risk Adapted Treatment Strategy, Including Gemtuzumab Ozogamicin (GO) During Consolidation, for Patients With Acute Myeloid Leukemia (AML) [Phase 4]
Phase 4 trial LAM07 completed evaluating a risk-adapted consolidation strategy that included Gemtuzumab ozogamicin for patients with acute m…
-
CLINICAL_TRIALS trial_result · 2013-07-23Clinical Trial Update: Cladribine Based Induction Therapy With All-Trans Retinoic Acid and Midostaurin in Relapsed/Refractory AML [Phase 1]
Phase 1 study investigating cladribine-based induction therapy combined with all-trans retinoic acid and midostaurin for relapsed/refractory…
-
CLINICAL_TRIALS trial_result · 2013-07-22Clinical Trial Update: Low Dose Melphalan and Bortezomib for AML and High-Risk MDS [NA]
Clinical trial of low-dose melphalan and bortezomib for acute myeloid leukemia and high-risk myelodysplastic syndromes has completed with re…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia [Phase 2]
Phase 2 study of VNP40101M in acute myeloid leukemia and high-risk myelodysplastic syndromes has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2013-07-17Clinical Trial Update: Clofarabine and Ara-C for the Treatment of Relapsed AML and Untreated MDS [Phase 2]
Phase 2 clinical trial evaluating the combination of clofarabine and cytarabine (Ara-C) for relapsed acute myeloid leukemia and untreated my…
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: A Randomized Study of Gemtuzumab Ozogamicin (GO) With Daunorubicine and Cytarabine in Untreated Acute Myeloid Leukemia (AML) Aged of 50-70 Years Old [Phase 3]
A Phase 3 randomized study evaluating gemtuzumab ozogamicin added to daunorubicin and cytarabine in untreated acute myeloid leukemia patient…
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome [Phase 2]
A phase 2 study of cediranib maleate in adults with relapsed/refractory or untreated acute myeloid leukemia or high-risk myelodysplastic syn…